Disease of creutzfeldt jakob: Hospital of San José, Bogotá D.C. Colombia
Enfermedad de creutzfeldt jakob: Hospital de San José, Bogotá D.C. Colombia
Article Sidebar
PDF (Español (España))
FLIP
How to Cite
Triana, J. D., & Pérez Rangel, A. (2015). Disease of creutzfeldt jakob: Hospital of San José, Bogotá D.C. Colombia. Journal of Medicine and Surgery Repertoire, 24(4), 298–302. https://doi.org/10.31260/RepertMedCir.v24.n4.2015.605
Section
Case Reports
License terms
Main Article Content
Abstract
It is estimated that the incidence of Creutzfeldt Jakob disease (CJD) is about one case per million inhabitants and although it is rare in those who suffer catastrophic consequences, with signs that usually start as a demential picture progressive and irreversible that inevitably results in death. There is no specific treatment and the diagnosis despite the great scientific advances is still puzzling, since the performance of the available tests is not the best. Perhaps it is the anatomopathological study that establishes the diagnosis, but disposable instruments are required that condition important costs to the health services, in addition to the high risk of infection to the medical personnel involved in the procedure. Abbreviations: CJD, Creutzfeldt Jakob disease; NMR, nuclear, magnetic resonance; VTM, videotelemetry.
Keywords:
Downloads
Download data is not yet available.
Article Details
References
1. Victor M, Adams RD, Ropper AH. Principios de neurología: McGraw-Hill Interamericana; 2004. Capítulo 33. Infecciones víricas del sistema nervioso, meningitis crónica y enfermedades por priones; p. 737-738.
2. Praveen K, Sinha S, Chandrasekhar H, Vijayan J, Taly A. Sporadic onset Creutzfeldt-Jacob disease: Interesting MRI observations. Neurology India. 2006; 54(4):418.
3. Mead S, Poulter M, Uphill J, Beck J, Whitfield J, Webb TEF, et al. Genetic risk factors for variant Creutzfeldt–Jakob disease: a genome-wide association study. The Lancet Neurology. 2009;8(1):57-66. doi:10.1016/S1474-4422(08)70265-5.
4. Vitali P, Maccagnano E, Caverzasi E, Henry RG, Haman A, Torres-Chae C, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011;76(20):1711-9. doi: 10.1212/WNL.0b013e31821a4439.
5. Geschwind MD, Potter CA, Sattavat M, Garcia PA, Rosen HJ, Miller BL, et al. Correlating DWI MRI with pathological and other features of Jakob-Creutzfeldt disease. Alzheimer disease and associated disorders. 2009;23(1):82-7.
6. Ukisu R, Kushihashi T, Tanaka E, Baba M, Usui N, Fujisawa H, et al. Diffusionweighted MR Imaging of Early-Stage Creutzfeldt-Jakob Disease: Typical and Atypical Manifestations 1. Radiographics. 2006;26(suppl_1):S191-S204. doi: 10.1148/rg.26si065503.
7. Murata T, Shiga Y, Higano S, Takahashi S, Mugikura S. Conspicuity and Evolution of Lesions in Creutzfeldt-Jakob Disease at Diffusion-Weighted Imaging. AJNR Am J Neuroradiol. 2002;23(7):1164-72.
8. Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132(10):2659-68. doi:10.1093/brain/awp191.
9. Jankovic J, Fenichel G, Daroff RB, Bradley WG. Neurología clínica. Barcelona, Elsevier España; 2010. Capítulo 57. Infecciones del sistema nervioso; p.1580-2.
10. Orrú CD, Bongianni M, Tonoli G, Ferrari S, Hughson AG, Groveman BR, et al. A Test for Creutzfeldt–Jakob Disease Using Nasal Brushings. New England Journal of Medicine. 2014;371(6):519-29. doi:10.1056/NEJMoa1315200.
11. Collinge J. New Diagnostic Tests for Prion Diseases. New England Journal of Medicine. 1996;335(13):963-5. doi: 10.1056/NEJM199609263351310.
12. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 Brain Protein in Cerebrospinal Fluid as a Marker for Transmissible Spongiform Encephalopathies. N Engl J Med. 1996;335(13):924-30. doi: 10.1056/NEJM199609263351303.
13. Cammaroto S, Smorto C, Galletta D, Bramanti P, Calabrò R. Autopsy-like MRI findings: report on Creutzfeldt–Jakob disease in the end-stage. Neurological Sciences. 2015;36(8):1497-9. doi: 10.1007/s10072-015-2112-6.
14. Markarian MF, Ojeda A, Uriarte AM. Enfermedad de Creutzfeldt-Jakob por RMI: alteración cortical como signo temprano de la enfermedad. Rev Argent Radiol. 2008;72(4):409-14.
15. Torres-Ramírez L, Ramírez-Quiñones J, Cosentino-Esquerre C, Vélez-Rojas M, Flores-Mendoza M, Rivas-Franchini D, et al. Enfermedad de creutzfeldt-jakob en el Perú: reporte de once casos. Rev. perú. med. exp. salud pública. 2014; 31(2):364-9.
2. Praveen K, Sinha S, Chandrasekhar H, Vijayan J, Taly A. Sporadic onset Creutzfeldt-Jacob disease: Interesting MRI observations. Neurology India. 2006; 54(4):418.
3. Mead S, Poulter M, Uphill J, Beck J, Whitfield J, Webb TEF, et al. Genetic risk factors for variant Creutzfeldt–Jakob disease: a genome-wide association study. The Lancet Neurology. 2009;8(1):57-66. doi:10.1016/S1474-4422(08)70265-5.
4. Vitali P, Maccagnano E, Caverzasi E, Henry RG, Haman A, Torres-Chae C, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011;76(20):1711-9. doi: 10.1212/WNL.0b013e31821a4439.
5. Geschwind MD, Potter CA, Sattavat M, Garcia PA, Rosen HJ, Miller BL, et al. Correlating DWI MRI with pathological and other features of Jakob-Creutzfeldt disease. Alzheimer disease and associated disorders. 2009;23(1):82-7.
6. Ukisu R, Kushihashi T, Tanaka E, Baba M, Usui N, Fujisawa H, et al. Diffusionweighted MR Imaging of Early-Stage Creutzfeldt-Jakob Disease: Typical and Atypical Manifestations 1. Radiographics. 2006;26(suppl_1):S191-S204. doi: 10.1148/rg.26si065503.
7. Murata T, Shiga Y, Higano S, Takahashi S, Mugikura S. Conspicuity and Evolution of Lesions in Creutzfeldt-Jakob Disease at Diffusion-Weighted Imaging. AJNR Am J Neuroradiol. 2002;23(7):1164-72.
8. Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132(10):2659-68. doi:10.1093/brain/awp191.
9. Jankovic J, Fenichel G, Daroff RB, Bradley WG. Neurología clínica. Barcelona, Elsevier España; 2010. Capítulo 57. Infecciones del sistema nervioso; p.1580-2.
10. Orrú CD, Bongianni M, Tonoli G, Ferrari S, Hughson AG, Groveman BR, et al. A Test for Creutzfeldt–Jakob Disease Using Nasal Brushings. New England Journal of Medicine. 2014;371(6):519-29. doi:10.1056/NEJMoa1315200.
11. Collinge J. New Diagnostic Tests for Prion Diseases. New England Journal of Medicine. 1996;335(13):963-5. doi: 10.1056/NEJM199609263351310.
12. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 Brain Protein in Cerebrospinal Fluid as a Marker for Transmissible Spongiform Encephalopathies. N Engl J Med. 1996;335(13):924-30. doi: 10.1056/NEJM199609263351303.
13. Cammaroto S, Smorto C, Galletta D, Bramanti P, Calabrò R. Autopsy-like MRI findings: report on Creutzfeldt–Jakob disease in the end-stage. Neurological Sciences. 2015;36(8):1497-9. doi: 10.1007/s10072-015-2112-6.
14. Markarian MF, Ojeda A, Uriarte AM. Enfermedad de Creutzfeldt-Jakob por RMI: alteración cortical como signo temprano de la enfermedad. Rev Argent Radiol. 2008;72(4):409-14.
15. Torres-Ramírez L, Ramírez-Quiñones J, Cosentino-Esquerre C, Vélez-Rojas M, Flores-Mendoza M, Rivas-Franchini D, et al. Enfermedad de creutzfeldt-jakob en el Perú: reporte de once casos. Rev. perú. med. exp. salud pública. 2014; 31(2):364-9.